1-8 of 8
Maksim Mamonkin, PhD
Close
Sort by
Journal Articles

Combinatorial Antigen Targeting Strategy for Acute Myeloid Leukemia

Pinar Ataca Atilla, MD, Mary K McKenna, PhD, Norihiro Watanabe, PhD, Maksim Mamonkin, PhD, Malcolm K. Brenner, MD PhD, Erden Atilla, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 22–23.
https://doi.org/10.1182/blood-2020-141540
Published: 2020
Journal Articles

Safety and Anti-Tumor Activity of CD5 CAR T-Cells in Patients with Relapsed/Refractory T-Cell Malignancies

LaQuisa C. Hill, MD, Rayne H. Rouce, MD, Tyler S. Smith, Lina Yang, PhD, Madhuwanti Srinivasan, Huimin Zhang, BS, Silvana Perconti, Birju Mehta, MS, BS, Olga Dakhova, Josalind Randall, Bambi J. Grilley, RPh, Helen E. Heslop, MD DSc, Malcolm K. Brenner, MD PhD, Maksim Mamonkin, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 199.
https://doi.org/10.1182/blood-2019-129559
Published: 2019
Journal Articles

Enhancing the Effect of CLL-1 CAR T Cells with Interleukin-15 for Treatment of Acute Myeloid Leukemia

Pinar Ataca Atilla, MD, Haruko Tashiro, MD PhD, Mary Kathryn McKenna, PhD, Madhuwanti Srinivasan, Brian Wesley Simons, Alexandra McLean Stevens, MD PhD, Michele Redell, MD PhD, Maksim Mamonkin, PhD, Malcolm K. Brenner, MD PhD, Erden Atilla, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3912.
https://doi.org/10.1182/blood-2019-127953
Published: 2019
Journal Articles

Engineering Naturally Occurring CD7 Negative Cells for the Immunotherapy of CD7 Positive Leukemia

Abdullah Freiwan, MSc, Abishek Vaidya, MS, Caitlin Zebley, MD, Yiping Fan, PhD, Deanna Langfitt, PhD, Benjamin Youngblood, PhD, Maksim Mamonkin, PhD, Stephen Gottschalk, MD, Mireya Paulina Velasquez, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 868.
https://doi.org/10.1182/blood-2019-124903
Published: 2019
Journal Articles

Chimeric Antigen Receptor (CAR) T Cell Therapy for CD7-Positive Acute Myeloid Leukemia

Diogo Gomes-Silva, Haruko Tashiro, MD PhD, Madhuwanti Srinivasan, Premal Lulla, MBBS, Malcolm K. Brenner, MD PhD, Maksim Mamonkin, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2642.
https://doi.org/10.1182/blood.V130.Suppl_1.2642.2642
Published: 2017
Journal Articles

CAR T Cells Targeted with a High Affinity Scfv Against the HCMV Glycoprotein Gb As Adoptive T Cell Therapy after Hematopoietic Stem Cell Transplantation

Renata Stripecke, PhD, Laura Gerasch, Sebastian Theobald, Bala Sai Sundarasetty, PhD, Maksim Mamonkin, PhD, Thomas Shum, BS, Cliona M. Rooney, PhD
Journal: Blood
Blood (2016) 128 (22): 5721.
https://doi.org/10.1182/blood.V128.22.5721.5721
Published: 2016
Journal Articles

Direct Comparison of In Vivo Fate of Second and Third-Generation CD19-Specific Chimeric Antigen Receptor (CAR)-T Cells in Patients with B-Cell Lymphoma: Reversal of Toxicity from Tonic Signaling

Diogo Gomes da Silva, Malini Mukherjee, Madhuwanti Srinivasan, Olga Dakhova, PhD, Hao Liu, PhD, Bambi Grilley, Adrian P. Gee, PhD, Sattva S. Neelapu, MD, Cliona M. Rooney, PhD, Helen E Heslop, MD DSc (Hon), Barbara Savoldo, MD PhD, Gianpietro Dotti, MD, Malcolm K. Brenner, MD PhD, Maksim Mamonkin, PhD, Carlos A. Ramos, MD
Journal: Blood
Blood (2016) 128 (22): 1851.
https://doi.org/10.1182/blood.V128.22.1851.1851
Published: 2016
Journal Articles

CD7 CAR for the Treatment of Acute Myeloid and Lymphoid Leukemia

Diogo Silva, Haruko Tashiro, MD PhD, Madhuwanti Srinivasan, Malcolm K. Brenner, MD PhD, Maksim Mamonkin, PhD
Journal: Blood
Blood (2016) 128 (22): 4555.
https://doi.org/10.1182/blood.V128.22.4555.4555
Published: 2016